Shandong Wohua Pharmaceutical Co., Ltd.

002107

CNE000001QB8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
5.08 ^CNY	+1.40%		+5.39%	-16.31%

Apr. 26	Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 01	Shandong Wohua Pharmaceutical Co., Ltd. Proposes Profit Distribution for 2023	CI

Shandong Wohua Pharmaceutical Co., Ltd. Declares Cash Dividend for A Shares for 2020, Payable on 09 April 2021

March 31, 2021 at 03:38 pm EDT

Shandong Wohua Pharmaceutical Co., Ltd. declares cash dividend of CNY 2.60000000 per ten shares (tax included) for A shares for 2020, payable on 09 April 2021. Record date is 08 April 2021 and Ex-date is 09 April 2021.

Latest news about Shandong Wohua Pharmaceutical Co., Ltd.

Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Shandong Wohua Pharmaceutical Co., Ltd. Proposes Profit Distribution for 2023	Apr. 01	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-28	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-15	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-15	CI
Wohua Pharmaceutical Sets Payment Date For 2021 Final Dividend	22-03-01	MT
Shandong Wohua Pharmaceutical Co., Ltd. Approves Dividend for the Year 2021, Payable on March 8, 2022	22-02-11	CI
Shandong Wohua Pharmaceutical Co., Ltd. Announces Executive Appointments	22-02-11	CI
Wohua Pharmaceutical Declares Final 2021 Dividend	22-01-23	MT
Shandong Wohua Pharmaceutical Co., Ltd. Proposes Dividend for the Year 2021	22-01-21	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-01-20	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-29	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-06	CI
Shandong Wohua Pharmaceutical Co., Ltd. Declares Cash Dividend for A Shares for 2020, Payable on 09 April 2021	21-03-31	CI
Beijing Tongfengtang Pharmaceutical Management Co., Ltd. cancelled the acquisition of Wohua Pharmaceutical International Co., Ltd. from Shandong Wohua Pharmaceutical Co., Ltd..	21-03-26	CI
Shandong Wohua Pharmaceutical Co., Ltd. Approves Distribution for 2020	21-02-22	CI
Shandong Wohua Pharmaceutical : Pharma Declares Cash Dividend	21-01-21	MT
Shandong Wohua Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2020	21-01-21	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-01-20	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-15	CI

Chart Shandong Wohua Pharmaceutical Co., Ltd.

Duration

Period

Chart Shandong Wohua Pharmaceutical Co., Ltd.

More charts

Company Profile

Shandong Wohua Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of Chinese traditional patent medicines. The Company's main products consist of Xinkeshu tablets for the treatment of coronary heart disease; Gushu tablets for the treatment of middle-aged and senile osteoporosis, and Hedan tablets for promoting blood circulation and for the treatment of hyperlipidemia. The Company distributes its products in domestic market, mainly in East China, North China and Northeast China.

Sector

Pharmaceuticals

Calendar

2024-05-15 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
SHANDONG WOHUA PHARMACEUTICAL CO., LTD.	-16.31%	400M
DONG-E-E-JIAO CO.,LTD.	+43.25%	6.3B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.08%	4.44B
TASLY PHARMACEUTICAL GROUP CO., LTD	-6.70%	3.27B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+5.47%	3.16B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+0.76%	2.58B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.75%	1.96B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-5.08%	1.73B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+2.05%	1.68B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-7.08%	1.63B

Alternative Medicine